BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36449115)

  • 21. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
    Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver.
    Aprahamian CJ; Chen M; Yang Y; Lorenz RG; Harmon CM
    J Pediatr Surg; 2007 Jun; 42(6):992-7. PubMed ID: 17560208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
    Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
    Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.
    Miyazaki M; Kato M; Tanaka K; Tanaka M; Kohjima M; Nakamura K; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R
    Mol Med Rep; 2012 Mar; 5(3):729-33. PubMed ID: 22179204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat.
    Mogilner JG; Srugo I; Lurie M; Shaoul R; Coran AG; Shiloni E; Sukhotnik I
    J Pediatr Surg; 2007 Aug; 42(8):1365-71. PubMed ID: 17706498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2.
    Ning MM; Yang WJ; Guan WB; Gu YP; Feng Y; Leng Y
    Acta Pharmacol Sin; 2020 Nov; 41(11):1446-1456. PubMed ID: 32398684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parenteral arginine impairs intestinal adaptation following massive small bowel resection in a rat model.
    Sukhotnik I; Mogilner JG; Lerner A; Coran AG; Lurie M; Miselevich I; Shiloni E
    Pediatr Surg Int; 2005 Jun; 21(6):460-5. PubMed ID: 15918043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enterohormone therapy for short bowel syndrome.
    Verbiest A; Wauters L; Vanuytsel T
    Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):207-218. PubMed ID: 35034035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
    Lai SW; de Heuvel E; Wallace LE; Hartmann B; Holst JJ; Brindle ME; Chelikani PK; Sigalet DL
    PLoS One; 2017; 12(7):e0181453. PubMed ID: 28738080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):463-74. PubMed ID: 20852989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ghrelin stimulates intestinal adaptation following massive small bowel resection in parenterally fed rats.
    Onishi S; Kaji T; Yamada W; Nakame K; Machigashira S; Kawano M; Yano K; Harumatsu T; Yamada K; Masuya R; Kawano T; Mukai M; Hamada T; Souda M; Yoshioka T; Tanimoto A; Ieiri S
    Peptides; 2018 Aug; 106():59-67. PubMed ID: 29966680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.
    Naimi RM; Madsen KB; Askov-Hansen C; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
    Regul Pept; 2013 Jun; 184():47-53. PubMed ID: 23501043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
    Vegge A; Thymann T; Lund P; Stoll B; Bering SB; Hartmann B; Jelsing J; Qvist N; Burrin DG; Jeppesen PB; Holst JJ; Sangild PT
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G277-85. PubMed ID: 23764891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population.
    Zheng T; Chen B; Yang L; Hu X; Zhang X; Liu H; Qin L
    Metabolism; 2017 Aug; 73():125-134. PubMed ID: 28637594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxemia inhibits intestinal adaptation in a rat model of short bowel syndrome.
    Sukhotnik I; Krausz MM; Sabo E; Resnick M; Hirsh M; Mannheim D; Shiloni E
    Shock; 2003 Jan; 19(1):66-70. PubMed ID: 12558147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous glucagon-like peptide-2 improves outcomes of intestinal adaptation in a distal-intestinal resection neonatal piglet model of short bowel syndrome.
    Suri M; Turner JM; Sigalet DL; Wizzard PR; Nation PN; Ball RO; Pencharz PB; Brubaker PL; Wales PW
    Pediatr Res; 2014 Oct; 76(4):370-7. PubMed ID: 24995913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
    Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
    Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Anatomy Does Not Affect the Progression of Intestinal Failure-Associated Liver Disease in Neonatal Piglets.
    Lavallee CM; Wizzard PR; Lansing M; Vine DF; Nation PN; Yap JY; Willing BP; Wales PW; Turner JM
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):14-23. PubMed ID: 28719764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.